VPC
Vestal Point Capital Portfolio holdings
AUM
$1.9B
1-Year Est. Return
12.28%
1 Year Est. Return
-12.28%
AUM
$1.4B
AUM Growth
-$286M
(-17%)
Holding
86
Top Buys
| 1 | +$125M | |
| 2 | +$50.3M | |
| 3 | +$41.8M | |
| 4 |
Vera Therapeutics
VERA
|
+$34.2M |
| 5 |
Nuvalent
NUVL
|
+$33.7M |
Top Sells
| 1 | +$120M | |
| 2 | +$79.6M | |
| 3 | +$57.6M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$56.5M |
| 5 |
Soleno Therapeutics
SLNO
|
+$47.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Neurogene
NGNE
$427M
| – | – |
-80,000
|
|
||
77
Intellia Therapeutics
NTLA
$2.75B
| – | – |
-525,000
|
|
||
78
Regeneron Pharmaceuticals
REGN
$61.3B
| – | – |
-20,000
|
|
||
79
Roivant Sciences
ROIV
$12.4B
| – | – |
-1,250,000
|
|
||
|
80
Soleno Therapeutics
SLNO
$3.41B
| – | – |
-1,060,000
|
|
||
81
Sanofi
SNY
$126B
| – | – |
-750,000
|
|
||
82
Transmedics
TMDX
$4.45B
| – | – |
-50,000
|
|
||
|
VERV
83
DELISTED
Verve Therapeutics
VERV
| – | – |
-645,000
|
|
||
84
Zai Lab
ZLAB
$2.93B
| – | – |
-300,000
|
|
||
|
CMRX
85
DELISTED
Chimerix, Inc.
CMRX
| – | – |
-1,400,000
|
|
||
|
ACHL
86
DELISTED
Achilles Therapeutics
ACHL
| – | – |
-1,500,000
|
|